Publication Name	World Journal of Hepatology
Manuscript ID	94729
Country	China

Received	2024-03-24 05:36
Peer-Review Started	2024-03-24 05:36
To Make the First Decision
Return for Revision	2024-04-13 16:19
Revised	2024-05-05 07:15
Second Decision	2024-06-03 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-03 07:44
Articles in Press	2024-06-03 07:44
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-12 06:59
Typeset the Manuscript	2024-06-17 00:27
Publish the Manuscript Online	2024-06-20 03:42

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis B cure: Current situation and prospects
Manuscript Source	Invited Manuscript
All Author List	Ya-Ping Li, Chen-Rui Liu, Ling He and Shuang-Suo Dang
ORCID	Author(s) ORCID Number Ya-Ping Li http://orcid.org/0000-0002-0900-5559 Shuang-Suo Dang http://orcid.org/0000-0003-0918-9535
Funding Agency and Grant Number	Funding Agency Grant Number Natural Science Basic Research Program of Shaanxi Province, China 2022JQ-916
Corresponding Author	Shuang-Suo Dang, PhD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 Xiwu Road, Xi’an 710004, Shaanxi Province, China. dang212@126.com
Key Words	Chronic hepatitis B; Clinical cure; Polyethylene glycol interferon; Treatment strategies; Research progress
Core Tip	Clinical cure has become an ideal goal pursued by chronic hepatitis B (CHB) patients. To enable more patients to achieve this goal, immunotherapy targets, the development of drugs targeting the viral life cycle, gene editing technologies, and the application of other methods have promoted the achievement of a clinical cure for CHB; however, this topic warrants continuous exploration.
Publish Date	2024-06-20 03:42
Citation	<p>Li YP, Liu CR, He L, Dang SS. Hepatitis B cure: Current situation and prospects. <i>World J Hepatol</i> 2024; 16(6): 900-911</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i6/900.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i6.900

Full Article (PDF)	WJH-16-900-with-cover.pdf
Manuscript File	94729_Auto_Edited-YJP_WangTQ.docx
Answering Reviewers	94729-answering-reviewers.pdf
Audio Core Tip	94729-audio.m4a
Conflict-of-Interest Disclosure Form	94729-conflict-of-interest-statement.pdf
Copyright License Agreement	94729-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	94729-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	94729-non-native-speakers.pdf
Peer-review Report	94729-peer-reviews.pdf
Scientific Misconduct Check	94729-scientific-misconduct-check.png
Scientific Editor Work List	94729-scientific-editor-work-list.pdf
CrossCheck Report	94729-crosscheck-report.png
CrossCheck Report	94729-crosscheck-report.pdf